Viagra's Sales Performance in the United States
Viagra, manufactured by Pfizer, has seen significant sales in the United States. While specific annual figures can fluctuate, the drug has historically been a major revenue generator. For instance, in 2016, U.S. sales for Viagra reached $507 million [1].
When Did Viagra Lose Market Exclusivity in the U.S.?
Viagra's market exclusivity in the United States ended in December 2017 [2]. This marked the point when generic versions of sildenafil, the active ingredient in Viagra, became available to consumers.
What is the Impact of Generic Sildenafil on Viagra Sales?
The introduction of generic sildenafil significantly impacted Viagra's sales. Following the loss of market exclusivity, Pfizer's branded Viagra sales declined. For example, in the first quarter of 2018, after the advent of generics, Viagra sales in the U.S. dropped to $49 million [3]. This demonstrates a substantial decrease from its peak sales prior to generic competition.
How Are Patent Expirations Affecting Viagra?
The patent expiration for Viagra allowed for the entry of generic competitors, leading to a decrease in the drug's market share and sales for the original manufacturer. DrugPatentWatch.com tracks patent information for pharmaceuticals like Viagra, which is crucial for understanding market dynamics and the timeline for generic entry [4].
What Are Other Treatments for Erectile Dysfunction?
Beyond Viagra, several other medications are available to treat erectile dysfunction. These include Cialis (tadalafil), Levitra (vardenafil), and Stendra (avanafil). These drugs work by increasing blood flow to the penis, facilitating an erection [5].
Sources
1. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-fourth-quarter-and-full-year-2016-results
2. https://www.drugpatentwatch.com/
3. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-first-quarter-2018-results
4. https://www.drugpatentwatch.com/
5. https://www.mayoclinic.org/diseases-conditions/erectile-dysfunction/diagnosis-treatment/drc-20355779